Immunology and Microbiology
Human Immunodeficiency Virus
100%
Human Immunodeficiency Virus 1
89%
T Cell
31%
CD4 Lymphocyte Count
29%
Human Immunodeficiency Virus Infection
27%
CD4
23%
T-Helper Cell
20%
Lymphocyte
18%
Viral Load
16%
Seroconversion
16%
Blood Plasma
14%
Acquired Immune Deficiency Syndrome
10%
Cytotoxic T-Cell
10%
Cytomegalovirus
8%
CD8
8%
CCR5
7%
Homeostasis
7%
Cytokine
6%
Monocyte
6%
Monospecific Antibody
6%
Viremia
6%
Cell Count
5%
CD3 Antigen
5%
Peripheral Blood Mononuclear Cell
5%
Keyphrases
Human Immunodeficiency Virus Type 1 (HIV-1)
54%
AIDS/HIV
38%
HIV Patients
29%
Multicenter AIDS Cohort Study
25%
Highly Active Antiretroviral Therapy (HAART)
22%
HIV Infection
15%
CD4+
13%
HIV-1 Infection
12%
CD4 Count
12%
Antiretroviral Therapy
12%
Human Immunodeficiency Virus Infection
11%
T Cells
11%
Confidence Interval
10%
Homosexual Men
9%
Seroconversion
9%
People Living with HIV (PLHIV)
8%
Disease Progression
8%
Aging
8%
Cytomegalovirus
8%
HIV+
7%
Seroconverter
7%
Frailty
7%
HIV Status
6%
CD4+ T Cells
6%
Lymphocytes
6%
HIV Viral Load
6%
Viral Load
6%
Non-Hodgkin Lymphoma
6%
Resting CD4+ T Cells
6%
Men Who Have Sex with Men
6%
Immune Activation
5%
T Cell Homeostasis
5%
CD8+ T Cells
5%
C-C Chemokine Receptor Type 5 (CCR5)
5%
Latent Reservoir
5%
HIV RNA
5%
CD4+ T
5%
HIV Disease Progression
5%
Living with
5%
Medicine and Dentistry
Human Immunodeficiency Virus
80%
Cohort Analysis
25%
Human Immunodeficiency Virus Infection
13%
Infection
13%
Highly Active Antiretroviral Therapy
12%
Antiretroviral Therapy
11%
Cell Count
10%
Lymphocyte
10%
T Cell
9%
T-Helper Cell
8%
Frailty
7%
Human Immunodeficiency Virus 1 Infection
7%
Human Immunodeficiency Virus 1
7%
Acquired Immune Deficiency Syndrome
6%
Cytomegalovirus
6%
Non-Hodgkin Lymphoma
5%